Increased expression of protein kinase A inhibitor α (PKI-α) and decreased PKA-regulated genes in chronic intermittent alcohol exposure

Brain Research

Volumn 1138, Issue 1, 2007, Pages 48-56

  Repunte Canonigo, Vez ^a   Lutjens, Robert ^a   van der Stap, Lena D ^a   Sanna, Pietro Paolo ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcoholism; cAMP; Dependence; Dopamine; Motivation; PKA; Relapse; Self administration

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOPAMINE; NEUROPEPTIDE; NUCLEAR RECEPTOR NUR77; PROTEIN KINASE A INHIBITOR ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG;

ACTIVITY AND NEUROTRANSMITTER REGULATED EARLY GENE 1; ACTIVITY AND NEUROTRANSMITTER REGULATED EARLY GENE 3; ACTIVITY AND NEUROTRANSMITTER REGULATED EARLY GENE 7; ACTIVITY AND NEUROTRANSMITTER REGULATED EARLY GENE 8; ALCOHOL CONSUMPTION; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DNA MICROARRAY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; EXPOSURE; GENE; GENE EXPRESSION REGULATION; LIMBIC CORTEX; MALE; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATOR GENE; REINFORCEMENT; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYGDALA; ANIMALS; BRAIN; CARRIER PROTEINS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG ADMINISTRATION SCHEDULE; EARLY GROWTH RESPONSE PROTEIN 1; ETHANOL; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 33847172394     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.115     Document Type: Article

References (69)

1. Abrous D.N., Desjardins S., Sorin B., Hancock D., Le Moal M., and Herman J.P. Changes in striatal immediate early gene expression following neonatal dopaminergic lesion and effects of intrastriatal dopaminergic transplants. Neuroscience 73 (1996) 145-159
2. Affymetrix, Statistical Algorithms Reference Guide, http://www.affymetrix.com/support/technical/technotes/statistical_reference_guide.pdf (2002).
3. Ahmed S.H., Lutjens R., van der Stap L.D., Lekic D., Romano-Spica V., Morales M., Koob G.F., Repunte-Canonigo V., and Sanna P.P. Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11533-11538
4. Asyyeda A., Stormb D., and Diamond I. Ethanol activates cAMP response element-mediated gene expression in select regions of the mouse brain. Brain Res. 1106 (2006) 63-71
5. Becker H.C., and Hale R.L. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling". Alcohol.: Clin. Exp. Res. 17 (1993) 94-98
6. Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., and Gerfen C.R. A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18 (1998) 5301-5310
7. Berke J.D., Sgambato V., Zhu P.P., Lavoie B., Vincent M., Krause M., and Hyman S.E. Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron 32 (2001) 277-287
8. Bottai D., Guzowski J.F., Schwarz M.K., Kang S.H., Xiao B., Lanahan A., Worley P.F., and Seeburg P.H. Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J. Neurosci. 22 (2002) 167-175
9. Buck K.J., Hahner L., Sikela J., and Harris R.A. Chronic ethanol treatment alters brain levels of gamma-aminobutyric acidA receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity. J. Neurochem. 57 (1991) 1452-1455
10. Cagetti E., Liang J., Spigelman I., and Olsen R.W. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol. Pharmacol. 63 (2003) 53-64
11. Chen X., Dai J.C., Orellana S.A., and Greenfield E.M. Endogenous protein kinase inhibitor gamma terminates immediate-early gene expression induced by cAMP-dependent protein kinase (PKA) signaling: termination depends on PKA inactivation rather than PKA export from the nucleus. J. Biol. Chem. 280 (2005) 2700-2707
12. Chergui K., Svenningsson P., Nomikos G.G., Gonon F., Fredholm B.B., and Svennson T.H. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9 (1997) 2370-2382
13. Constantinescu A., Diamond I., and Gordon A.S. Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. J. Biol. Chem. 274 (1999) 26985-26991
14. Constantinescu A., Gordon A.S., and Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol. J. Biol. Chem. 277 (2002) 18810-18816
15. Devaud L.L., Fritschy J.M., Sieghart W., and Morrow A.L. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J. Neurochem. 69 (1997) 126-130
16. Diana M., Gessa G.L., and Rossetti Z.L. Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. Alcohol Alcohol. 27 (1992) 329-333
17. Diana M., Pistis M., Muntoni A., Rossetti Z.L., and Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. Eur. J. Pharmacol. 221 (1992) 403-404
18. Diana M., Pistis M., Carboni S., Gessa G.L., and Rossetti Z.L. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7966-7969
19. Dohrman D.P., Diamond I., and Gordon A.S. Ethanol causes sustained translocation of PKA C-alpha to the nucleus. RSA Meeting Abstract (1996) 586
20. Froehlich J.C., and Wand G.S. Adenylyl cyclase signal transduction and alcohol-induced sedation. Pharmacol. Biochem. Behav. 58 (1997) 1021-1030
21. Gilby K.L., Da Silva A.G., and McIntyre D.C. Differential GABA(A) subunit expression following status epilepticus in seizure-prone and seizure- resistant rats: a putative mechanism for refractory drug response. Epilepsia 46 Suppl. 5 (2005) 3-9
22. Imperato A., and Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239 (1986) 219-228
23. Izzo E., Sanna P., and Koob G. Impairment of dopaminergic system function after chronic treatment with corticotropin releasing factor. Pharmacol. Biochem. Behav. 81 (2005) 701-708
24. Jung A.B., and Bennett Jr. J.P. Development of striatal dopaminergic function: II. Dopaminergic regulation of transcription of the immediate early gene zif268 and of D1 (D1a) and D2 (D2a) receptors during pre- and postnatal development. Brain Res. Dev. Brain Res. 94 (1996) 121-132
25. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162 (2005) 1403-1413
26. Kammermeier P.J. Surface clustering of metabotropic glutamate receptor 1 induced by long Homer proteins. BMC Neurosci. 7 (2006) 1
27. Knighton D.R., Zheng J.H., Ten Eyck L.F., Xuong N.H., Taylor S.S., and Sowadski J.M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253 (1991) 414-420
28. Koob G.F. Alcoholism: allostasis and beyond. Alcohol.: Clin. Exp. Res. 27 (2003) 232-243
29. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
30. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., and Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
31. Leshner A.I. Addiction is a brain disease, and it matters. Science 278 (1997) 45-47
32. Leshner A.I., and Koob G.F. Drugs of abuse and the brain. Proc. Assoc. Am. Physicians 111 (1999) 99-108
33. Mailliard W., and Diamond I. Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol. Ther. 101 (2004) 39-46
34. Melis M., Spiga S., and Diana M. The dopamine hypothesis of drug addiction: hypodopaminergic state. Int. Rev. Neurobiol. 63 (2005) 101-154
35. Mhatre M.C., and Ticku M.K. Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression. Mol. Pharmacol. 42 (1992) 415-422
36. Mhatre M., and Ticku M.K. Chronic ethanol treatment upregulates the GABA receptor beta subunit expression. Brain Res. Mol. Brain Res. 23 (1994) 246-252
37. Mitsuyama H., Little K.Y., Sieghart W., Devaud L.L., and Morrow A.L. GABA(A) receptor alpha1, alpha4, and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics. Alcohol.: Clin. Exp. Res. 22 (1998) 815-822
38. Nairn A.C., and Greengard P. A novel cyclin provides a link between dopamine and RNA processing. Neuron 32 (2001) 174-176
39. O'Dell L.E., Roberts A.J., Smith R.T., and Koob G.F. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol.: Clin. Exp. Res. 28 (2004) 1676-1682
40. Oiwa Y., Yoshimura R., Nakai K., and Itakura T. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. Brain Res. 947 (2002) 271-283
41. Overstreet D.H., Knapp D.J., and Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol.: Clin. Exp. Res. 26 (2002) 1259-1268
42. Pandey S.C., Roy A., Zhang H., and Xu T. Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J. Neurosci. 24 (2004) 5022-5030
43. Papadeas S.T., Blake B.L., Knapp D.J., and Breese G.R. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement. J. Neurosci. 24 (2004) 5863-5876
44. Paul M.L., Graybiel A.M., David J.C., and Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12 (1992) 3729-3742
45. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edition (1998), Academic Press, San Diego
46. Rimondini R., Arlinde C., Sommer W., and Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 16 (2002) 27-35
47. Roberts A.J., Heyser C.J., Cole M., Griffin P., and Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22 (2000) 581-594
48. Roberto M., Nelson T.E., Ur C.L., Brunelli M., Sanna P.P., and Gruol D.L. The transient depression of hippocampal CA1 LTP induced by chronic intermittent ethanol exposure is associated with an inhibition of the MAP kinase pathway. Eur. J. Neurosci. 17 (2003) 1646-1654
49. Salin P., Kerkerian L., and Nieoullon A. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Exp. Brain Res. 81 (1990) 363-371
50. Sanna P.P., Folsom D.P., Barizo M.J., Hirsch M.D., Melia K.R., Maciejewski L.D., and Bloom F.E. Chronic ethanol intake decreases vasopressin mRNA content in the rat hypothalamus: a PCR study. Brain Res. Mol. Brain Res. 19 (1993) 241-245
51. Sanna P.P., Simpson C., Lutjens R., and Koob G. ERK regulation in chronic ethanol exposure and withdrawal. Brain Res. 948 (2002) 186-191
52. Sanna E., Mostallino M.C., Busonero F., Talani G., Tranquilli S., Mameli M., Spiga S., Follesa P., and Biggio G. Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J. Neurosci. 23 (2003) 11711-11724
53. Sanna P.P., King A.R., van der Stap L.D., and Repunte-Canonigo V. Gene profiling of laser-microdissected brain regions and sub-regions. Brain Res. Brain Res. Protoc. 15 (2005) 66-74
54. Self D.W., McClenahan A.W., Beitner-Johnson D., Terwilliger R.Z., and Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21 (1995) 312-318
55. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., and Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18 (1998) 1848-1859
56. Sgambato V., Minassian R., Nairn A.C., and Hyman S.E. Regulation of ania-6 splice variants by distinct signaling pathways in striatal neurons. J. Neurochem. 86 (2003) 153-164
57. Sgambato-Faure V., Xiong Y., Berke J.D., Hyman S.E., and Strehler E.E. The Homer-1 protein Ania-3 interacts with the plasma membrane calcium pump. Biochem. Biophys. Res. Commun. 343 (2006) 630-637
58. Slawecki C.J., Somes C., and Ehlers C.L. Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y. Alcohol Alcohol. 34 (1999) 289-299
59. Slawecki C.J., Betancourt M., Cole M., and Ehlers C.L. Periadolescent alcohol exposure has lasting effects on adult neurophysiological function in rats. Brain Res. Dev. Brain Res. 128 (2001) 63-72
60. Snyder-Keller A., Chandra R., Lin Y., and Mitchell E.S. Basal EGR-1 (zif268, NGFI-A, Krox-24) expression in developing striatal patches: role of dopamine and glutamate. Brain Res. 958 (2002) 297-304
61. Valjent E., Aubier B., Corbille A.G., Brami-Cherrier K., Caboche J., Topilko P., Girault J.A., and Herve D. Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine. J. Neurosci. 26 (2006) 4956-4960
62. Valjent E., Corbille A.G., Bertran-Gonzalez J., Herve D., and Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2932-2937
63. Wahlestedt C., Karoum F., Jaskiw G., Wyatt R.J., Larhammar D., Ekman R., and Reis D.J. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2078-2082
64. Wand G., Levine M., Zweifel L., Schwindinger W., and Abel T. The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. J. Neurosci. 21 (2001) 5297-5303
65. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr. Opin. Pharmacol. 5 (2005) 9-19
66. Weiss F., and Porrino L.J. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J. Neurosci. 22 (2002) 3332-3337
67. Weiss F., Parsons L.H., Schulteis G., Hyytia P., Lorang M.T., Bloom F.E., and Koob G.F. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 16 (1996) 3474-3485
68. Zigmond M.J., and Stricker E.M. Parkinson's disease: studies with an animal model. Life Sci. 35 (1984) 5-18
69. Zigmond M.J., Hastings T.G., and Perez R.G. Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity?. Parkinsonism Relat. Disord. 8 (2002) 389-393